Review



pre coated proteome profiler array membranes  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems pre coated proteome profiler array membranes
    Benzo-17R-RvD2 mimetic in peritonitis limits PMN tissue infiltration and regulates cytokines Mice were administered with vehicle or benzo-17R-RvD2 (1 ng/mouse) together with zymosan A (1 mg/mouse, i.p.) and exudates collected at 4 h. Total leukocytes were enumerated and composition determined by flow cytometry (see B for gating strategy). (A) Exudate PMN numbers; mean ± SEM, n = 4 mice each group, ∗∗ p < 0.01. (B) <t>Proteome</t> analysis was carried out with inflammatory exudates from four individual mice in each group using Proteome Profiler cytokine arrays, which contains 40 cytokines, chemokines, and acute phase proteins. Orthogonal Partial Least Squares Discriminant Analysis (PLS-DA): the score plot (each dot represents the cytokine profile from each mouse) shows clustering among groups (i.e., peritonitis vs. peritonitis plus benzo-17R-RvD2). The loading plot demonstrates correlations in which the measured cytokines contribute to the cluster separation in the score plot. (C) Relative intensities of cytokines, chemokines, and acute phase proteins. Proteome arrays consist of 40 proteins. Among them 18 were present in the peritoneal exudates. Results are mean ± SEM; relative abundance from n = 4 individual mouse exudates, ∗ p < 0.05, ∗∗ p < 0.01; peritonitis plus benzo-17R-RvD2 versus peritonitis alone; Student’s t test.
    Pre Coated Proteome Profiler Array Membranes, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 769 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Proteome+Profiler+Mouse+Cytokine+Array+Kit%2C+Panel+A/pmc12757561-336-8-14
    Average 96 stars, based on 769 article reviews
    pre coated proteome profiler array membranes - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Nouveau benzo-mimetics of 17R-Resolvin D2 are potent resolution agonists for inflammation"

    Article Title: Nouveau benzo-mimetics of 17R-Resolvin D2 are potent resolution agonists for inflammation

    Journal: iScience

    doi: 10.1016/j.isci.2025.114201

    Benzo-17R-RvD2 mimetic in peritonitis limits PMN tissue infiltration and regulates cytokines Mice were administered with vehicle or benzo-17R-RvD2 (1 ng/mouse) together with zymosan A (1 mg/mouse, i.p.) and exudates collected at 4 h. Total leukocytes were enumerated and composition determined by flow cytometry (see B for gating strategy). (A) Exudate PMN numbers; mean ± SEM, n = 4 mice each group, ∗∗ p < 0.01. (B) Proteome analysis was carried out with inflammatory exudates from four individual mice in each group using Proteome Profiler cytokine arrays, which contains 40 cytokines, chemokines, and acute phase proteins. Orthogonal Partial Least Squares Discriminant Analysis (PLS-DA): the score plot (each dot represents the cytokine profile from each mouse) shows clustering among groups (i.e., peritonitis vs. peritonitis plus benzo-17R-RvD2). The loading plot demonstrates correlations in which the measured cytokines contribute to the cluster separation in the score plot. (C) Relative intensities of cytokines, chemokines, and acute phase proteins. Proteome arrays consist of 40 proteins. Among them 18 were present in the peritoneal exudates. Results are mean ± SEM; relative abundance from n = 4 individual mouse exudates, ∗ p < 0.05, ∗∗ p < 0.01; peritonitis plus benzo-17R-RvD2 versus peritonitis alone; Student’s t test.
    Figure Legend Snippet: Benzo-17R-RvD2 mimetic in peritonitis limits PMN tissue infiltration and regulates cytokines Mice were administered with vehicle or benzo-17R-RvD2 (1 ng/mouse) together with zymosan A (1 mg/mouse, i.p.) and exudates collected at 4 h. Total leukocytes were enumerated and composition determined by flow cytometry (see B for gating strategy). (A) Exudate PMN numbers; mean ± SEM, n = 4 mice each group, ∗∗ p < 0.01. (B) Proteome analysis was carried out with inflammatory exudates from four individual mice in each group using Proteome Profiler cytokine arrays, which contains 40 cytokines, chemokines, and acute phase proteins. Orthogonal Partial Least Squares Discriminant Analysis (PLS-DA): the score plot (each dot represents the cytokine profile from each mouse) shows clustering among groups (i.e., peritonitis vs. peritonitis plus benzo-17R-RvD2). The loading plot demonstrates correlations in which the measured cytokines contribute to the cluster separation in the score plot. (C) Relative intensities of cytokines, chemokines, and acute phase proteins. Proteome arrays consist of 40 proteins. Among them 18 were present in the peritoneal exudates. Results are mean ± SEM; relative abundance from n = 4 individual mouse exudates, ∗ p < 0.05, ∗∗ p < 0.01; peritonitis plus benzo-17R-RvD2 versus peritonitis alone; Student’s t test.

    Techniques Used: Flow Cytometry

    Related Articles

    Ab Array:

    Article Title: Metabolic glycan labeling induces state-dependent remodeling of macrophage phenotype and metabolism
    Article Snippet: .. Cytokine levels in M1 macrophage culture supernatants (PBS versus AAM-treated, 50 μM, 48 h) were profiled with the Proteome Profiler Mouse Cytokine Array Kit, Panel A (R&D Systems, ARY006) according to the manufacturer's instructions, using 400 μL of supernatant per array (one array per condition). .. Chemiluminescent signals were acquired on an Amersham ImageQuant 800 Fluor (Cytiva) at three exposure times (24 s, 1 min, and 2 min) and saved as 16-bit TIFF images.

    Article Title: CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiring
    Article Snippet: Total protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, USA). .. For cytokine profiling, the Mouse Cytokine Array Panel A (Catalog #ARY006, R&D Systems, USA) was used according to the manufacturer’s instructions (Supplementary Table). .. Signal detection was performed using the Amersham Imager System (GE Healthcare, USA), and signals were normalized to positive control spots on each membrane and background-subtracted using ImageJ software.

    Article Title: Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer.
    Article Snippet: .. Secreted cytokines and chemokines induced by KRASG12D peptide stimulation were analyzed using a mouse cytokine array panel A kit (R&D Systems, ARY006) according to the instructions of the manufacturer. ..

    Article Title: cis-γ-Amino-L-proline peptides as chemical probes of amyloidogenic processing in neurons and APP/PS1 mice
    Article Snippet: .. Cytokine antibody array was performed with the mouse cytokine array panel A (ARY006, RD Systems). ..

    Cytokine Assay:

    Article Title: CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiring
    Article Snippet: Total protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, USA). .. For cytokine profiling, the Mouse Cytokine Array Panel A (Catalog #ARY006, R&D Systems, USA) was used according to the manufacturer’s instructions (Supplementary Table). .. Signal detection was performed using the Amersham Imager System (GE Healthcare, USA), and signals were normalized to positive control spots on each membrane and background-subtracted using ImageJ software.



    Similar Products

    93
    RayBiotech inc membrane based antibody array
    Membrane Based Antibody Array, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Rat+Growth+Factor+Array+1/bio_rxiv__64898__2026__11__03__763998-63-2-16
    Average 93 stars, based on 1 article reviews
    membrane based antibody array - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    RayBiotech inc human cytokine array c5 membrane kit
    (A) Schematic of the generation of synovium-on-a-chip models using synovial tissue and blood samples from patients with RA or osteoarthritis (OA) for comparative assessment of disease-associated phenotypes. (B) Representative immunofluorescence images and quantification of collagen IV deposition in RA and OA chips on days 3, 6, and 9 (n = 3 chips per condition per time point; Comparisons between RA and OA chips at each time point were performed using two-tailed unpaired Welch’s t-tests with Šídák correction for three comparisons; P values indicated). Scale bar, 50 μm. (C) Heatmap showing secretion profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in OA and RA chip culture medium pooled from 3 independently cultured chips on day 12. Color scale indicates log₁₀-transformed relative secretion values. (D) Quantification of Ki67⁺ lining FLS. Each dot represents the mean value for one chip (n = 3 chips; two-tailed unpaired t-test; P < 0.0001). (E) Representative immune cell migration trajectories and quantification of migration distance in RA and OA chips (three technical replicates with >45 immune cells per condition, two-tailed unpaired t-test, P <0.0001) (F) Quantification of the HLA-DR/CD163 ratio as an indicator of macrophage polarization (n = 3 chips per condition). (G) Temporal profiles of IL-6 concentrations in culture medium collected from RA and OA chips on days 4, 6, 8, 10, and 12 (n = 3 chips per condition per time point). IL-6 concentrations on day 12 were compared between RA and OA chips using a two-tailed unpaired t-test (P = 0.0058). (H) Multiplex profiling of cytokines associated with inflammation, immune regulation, chemotaxis, and growth in RA and OA chips on day 12. Each dot represents one patient, measured using culture medium pooled from 3 independently cultured chips; 2 patients were analyzed per group. Horizontal lines indicate group means. Values represent log₁₀-transformed relative <t>cytokine</t> secretion. Bars and error bars in (B), (D–G) indicate mean ± SD.
    Human Cytokine Array C5 Membrane Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Human+Cytokine+Array+C5/bio_rxiv__64898__2026__10__30__763140-282-7-15
    Average 97 stars, based on 1 article reviews
    human cytokine array c5 membrane kit - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    RayBiotech inc mouse cytokine array c3 membrane
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Mouse Cytokine Array C3 Membrane, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Mouse+Cytokine+Array+C3/bio_rxiv__64898__2026__10__27__762341-96-10-20
    Average 95 stars, based on 1 article reviews
    mouse cytokine array c3 membrane - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    R&D Systems membrane based array
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Membrane Based Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Proteome+Profiler+Human+XL+Cytokine+Array+Kit/pm42830288-321-8-17
    Average 96 stars, based on 1 article reviews
    membrane based array - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    RayBiotech inc sandwich based membrane antibody arrays
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Sandwich Based Membrane Antibody Arrays, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Human+Cytokine+Array+C2000/pm42809553-87-0-5
    Average 94 stars, based on 1 article reviews
    sandwich based membrane antibody arrays - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    RayBiotech inc canine cytokine array c1 membranes
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Canine Cytokine Array C1 Membranes, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Canine+Cytokine+Array+C1/10__21203_slash_rs__3__rs___10554309_slash_v1-150-8-13
    Average 94 stars, based on 1 article reviews
    canine cytokine array c1 membranes - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    RayBiotech inc membrane based raybio human cytokine antibody array 5
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Membrane Based Raybio Human Cytokine Antibody Array 5, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Human+Cytokine+Array+C5/pm42472532-77-13-14
    Average 97 stars, based on 1 article reviews
    membrane based raybio human cytokine antibody array 5 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    95
    RayBiotech inc human cytokine antibody array c3 membranes
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Human Cytokine Antibody Array C3 Membranes, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Human+Cytokine+Array+C3/pm42685639-127-9-15
    Average 95 stars, based on 1 article reviews
    human cytokine antibody array c3 membranes - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    RayBiotech inc separate raybiotech mouse cytokine array c3 membrane
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Separate Raybiotech Mouse Cytokine Array C3 Membrane, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Mouse+Cytokine+Array+C3/pmc13206757-79-7-8
    Average 95 stars, based on 1 article reviews
    separate raybiotech mouse cytokine array c3 membrane - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    RayBiotech inc human neuro discovery array c2 membrane
    (A,B) Comparison of <t>cytokine</t> profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.
    Human Neuro Discovery Array C2 Membrane, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/array+membranes/Human+Neuro+Discovery+Array+C2/10__1016_slash_j__mtadv__2026__100779-137-19-26
    Average 94 stars, based on 1 article reviews
    human neuro discovery array c2 membrane - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic of the generation of synovium-on-a-chip models using synovial tissue and blood samples from patients with RA or osteoarthritis (OA) for comparative assessment of disease-associated phenotypes. (B) Representative immunofluorescence images and quantification of collagen IV deposition in RA and OA chips on days 3, 6, and 9 (n = 3 chips per condition per time point; Comparisons between RA and OA chips at each time point were performed using two-tailed unpaired Welch’s t-tests with Šídák correction for three comparisons; P values indicated). Scale bar, 50 μm. (C) Heatmap showing secretion profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in OA and RA chip culture medium pooled from 3 independently cultured chips on day 12. Color scale indicates log₁₀-transformed relative secretion values. (D) Quantification of Ki67⁺ lining FLS. Each dot represents the mean value for one chip (n = 3 chips; two-tailed unpaired t-test; P < 0.0001). (E) Representative immune cell migration trajectories and quantification of migration distance in RA and OA chips (three technical replicates with >45 immune cells per condition, two-tailed unpaired t-test, P <0.0001) (F) Quantification of the HLA-DR/CD163 ratio as an indicator of macrophage polarization (n = 3 chips per condition). (G) Temporal profiles of IL-6 concentrations in culture medium collected from RA and OA chips on days 4, 6, 8, 10, and 12 (n = 3 chips per condition per time point). IL-6 concentrations on day 12 were compared between RA and OA chips using a two-tailed unpaired t-test (P = 0.0058). (H) Multiplex profiling of cytokines associated with inflammation, immune regulation, chemotaxis, and growth in RA and OA chips on day 12. Each dot represents one patient, measured using culture medium pooled from 3 independently cultured chips; 2 patients were analyzed per group. Horizontal lines indicate group means. Values represent log₁₀-transformed relative cytokine secretion. Bars and error bars in (B), (D–G) indicate mean ± SD.

    Journal: bioRxiv

    Article Title: Patient-Derived Synovium-on-a-Chip Recapitulates Disease and Treatment Response and Permits Study of Resistance in Rheumatoid Arthritis

    doi: 10.64898/2026.10.30.763140

    Figure Lengend Snippet: (A) Schematic of the generation of synovium-on-a-chip models using synovial tissue and blood samples from patients with RA or osteoarthritis (OA) for comparative assessment of disease-associated phenotypes. (B) Representative immunofluorescence images and quantification of collagen IV deposition in RA and OA chips on days 3, 6, and 9 (n = 3 chips per condition per time point; Comparisons between RA and OA chips at each time point were performed using two-tailed unpaired Welch’s t-tests with Šídák correction for three comparisons; P values indicated). Scale bar, 50 μm. (C) Heatmap showing secretion profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in OA and RA chip culture medium pooled from 3 independently cultured chips on day 12. Color scale indicates log₁₀-transformed relative secretion values. (D) Quantification of Ki67⁺ lining FLS. Each dot represents the mean value for one chip (n = 3 chips; two-tailed unpaired t-test; P < 0.0001). (E) Representative immune cell migration trajectories and quantification of migration distance in RA and OA chips (three technical replicates with >45 immune cells per condition, two-tailed unpaired t-test, P <0.0001) (F) Quantification of the HLA-DR/CD163 ratio as an indicator of macrophage polarization (n = 3 chips per condition). (G) Temporal profiles of IL-6 concentrations in culture medium collected from RA and OA chips on days 4, 6, 8, 10, and 12 (n = 3 chips per condition per time point). IL-6 concentrations on day 12 were compared between RA and OA chips using a two-tailed unpaired t-test (P = 0.0058). (H) Multiplex profiling of cytokines associated with inflammation, immune regulation, chemotaxis, and growth in RA and OA chips on day 12. Each dot represents one patient, measured using culture medium pooled from 3 independently cultured chips; 2 patients were analyzed per group. Horizontal lines indicate group means. Values represent log₁₀-transformed relative cytokine secretion. Bars and error bars in (B), (D–G) indicate mean ± SD.

    Article Snippet: Qualitative cytokine profiles were assessed using a Human Cytokine Array C5 membrane kit (catalogue AAH-CYT-5-8, RayBiotech) according to the manufacturer’s protocol.

    Techniques: Tissue, Blood/Plasma/Serum Samples, Immunofluorescence, Two Tailed Test, Cell Culture, Transformation Assay, Immune Cell, Migration, Multiplex Assay, Profiling, Chemotaxis Assay

    (A) Workflow for treatment prediction using patient-derived RA synovium-on-a-chip. Patient-derived chips were subjected to parallel drug perturbation with tocilizumab (IL-6 receptor antagonist, IL-6Ra), infliximab (TNF inhibitor, TNFi) and tofacitinib (JAK inhibitor, JAKi). Four functional readouts were quantified: stromal (ECM remodeling), cytokine (IL-6 secretion), immune (CD45⁺ cell count) and recruitment (immune cell migration distance). Treatment-induced changes relative to matched untreated controls were calculated as fold changes (treated/untreated), standardized within each patient across the three drug treatments (IL-6Ra, TNFi and JAKi), and combined into a composite on-chip response score to predict therapeutic outcome; the four features are also displayed as radar plots for visualization. (B) Heatmap of treatment-induced changes in the four readouts across nine patients and three drug conditions per patient. Rows represent patients, and columns represent readout–treatment combinations. Colors indicate standardized treatment-induced changes, with red indicating increases and blue indicating decreases. Patients were hierarchically clustered using unsupervised Ward’s linkage (ward.D2). Top annotations indicate on-chip treatment; right annotations indicate clinical response history to TNFi and JAKi treatment. Each value represents the mean of 3 chips per condition. (C) Composite treatment response score (mean of the four z-score–normalized readouts) quantified for each patient across IL-6Ra, TNFi and JAKi treatments, demonstrating patient-specific and drug-specific variation in composite response magnitude. (D) Correlation the composite on-chip response score for the clinically matched treatment and clinical improvement measured as ΔDAS28–ESR. Six matched patient–treatment observations from 5 independent patients are shown. Circles indicate TNFi and diamonds indicate JAKi treatment. Pearson r = 0.844, P = 0.0348; Spearman ρ = 0.943, P = 0.0167; both tests were two-tailed. The line represents the fitted linear regression (y = 3.444x + 0.505), and the shaded band indicates 95% confidence interval of the fit. (E) Feature contribution to prediction assessed by LOOCV root mean square error (RMSE) for individual features (migration distance, IL-6, collagen IV and CD45⁺ count, grey), integrated composite score (red) and clinical predictors (baseline DAS28 and JIS-defined inflammatory endotype, blue). The dashed line shows the null model baseline; The integrated composite score achieved the lowest RMSE. The asterisk denotes a prediction error significantly lower than expected by chance for the composite score (permutation test, p = 0.021). (F) Chip-based predicted treatment-response categories across nine patients and three drug conditions. Composite on-chip scores were converted into predicted ΔDAS28–ESR values using the regression model in panel D and classified as good, moderate, or no response according to clinical standard (Good: ΔDAS28–ESR>1.2; Moderate: 0.6 <ΔDAS28– ESR ≤ 1.2; No response: ΔDAS28–ESR ≤ 0.6). Green, yellow, and gray indicate the respective predicted categories.

    Journal: bioRxiv

    Article Title: Patient-Derived Synovium-on-a-Chip Recapitulates Disease and Treatment Response and Permits Study of Resistance in Rheumatoid Arthritis

    doi: 10.64898/2026.10.30.763140

    Figure Lengend Snippet: (A) Workflow for treatment prediction using patient-derived RA synovium-on-a-chip. Patient-derived chips were subjected to parallel drug perturbation with tocilizumab (IL-6 receptor antagonist, IL-6Ra), infliximab (TNF inhibitor, TNFi) and tofacitinib (JAK inhibitor, JAKi). Four functional readouts were quantified: stromal (ECM remodeling), cytokine (IL-6 secretion), immune (CD45⁺ cell count) and recruitment (immune cell migration distance). Treatment-induced changes relative to matched untreated controls were calculated as fold changes (treated/untreated), standardized within each patient across the three drug treatments (IL-6Ra, TNFi and JAKi), and combined into a composite on-chip response score to predict therapeutic outcome; the four features are also displayed as radar plots for visualization. (B) Heatmap of treatment-induced changes in the four readouts across nine patients and three drug conditions per patient. Rows represent patients, and columns represent readout–treatment combinations. Colors indicate standardized treatment-induced changes, with red indicating increases and blue indicating decreases. Patients were hierarchically clustered using unsupervised Ward’s linkage (ward.D2). Top annotations indicate on-chip treatment; right annotations indicate clinical response history to TNFi and JAKi treatment. Each value represents the mean of 3 chips per condition. (C) Composite treatment response score (mean of the four z-score–normalized readouts) quantified for each patient across IL-6Ra, TNFi and JAKi treatments, demonstrating patient-specific and drug-specific variation in composite response magnitude. (D) Correlation the composite on-chip response score for the clinically matched treatment and clinical improvement measured as ΔDAS28–ESR. Six matched patient–treatment observations from 5 independent patients are shown. Circles indicate TNFi and diamonds indicate JAKi treatment. Pearson r = 0.844, P = 0.0348; Spearman ρ = 0.943, P = 0.0167; both tests were two-tailed. The line represents the fitted linear regression (y = 3.444x + 0.505), and the shaded band indicates 95% confidence interval of the fit. (E) Feature contribution to prediction assessed by LOOCV root mean square error (RMSE) for individual features (migration distance, IL-6, collagen IV and CD45⁺ count, grey), integrated composite score (red) and clinical predictors (baseline DAS28 and JIS-defined inflammatory endotype, blue). The dashed line shows the null model baseline; The integrated composite score achieved the lowest RMSE. The asterisk denotes a prediction error significantly lower than expected by chance for the composite score (permutation test, p = 0.021). (F) Chip-based predicted treatment-response categories across nine patients and three drug conditions. Composite on-chip scores were converted into predicted ΔDAS28–ESR values using the regression model in panel D and classified as good, moderate, or no response according to clinical standard (Good: ΔDAS28–ESR>1.2; Moderate: 0.6 <ΔDAS28– ESR ≤ 1.2; No response: ΔDAS28–ESR ≤ 0.6). Green, yellow, and gray indicate the respective predicted categories.

    Article Snippet: Qualitative cytokine profiles were assessed using a Human Cytokine Array C5 membrane kit (catalogue AAH-CYT-5-8, RayBiotech) according to the manufacturer’s protocol.

    Techniques: Derivative Assay, Functional Assay, Cell Characterization, Immune Cell, Migration, Two Tailed Test

    (A,B) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.

    Journal: bioRxiv

    Article Title: Foreign Body Responses Adapt to Systemic Immunosuppression to Maintain Local Immune Homeostasis Through Decorin-Associated Signaling

    doi: 10.64898/2026.10.27.762341

    Figure Lengend Snippet: (A,B) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds, lungs, and livers of LPS-tolerant mice and their corresponding tissues from healthy controls. (C, D) Comparison of cytokine profiles and representative cytokine levels in conditioned media collected from implanted scaffolds and lungs of 4T1 tumor-bearing mice and their corresponding tissues from healthy controls. ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Student’s t -test.

    Article Snippet: Cytokine profiles in the conditioned media were analyzed using the Mouse Cytokine Array C3 membrane according to the manufacturer’s instructions (RayBiotech).

    Techniques: Comparison